Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin

Photochemistry and Photobiology

Volumn 90, Issue 4, 2014, Pages 896-902

  Middelburg, Tom A ^a   De Vijlder, Hannah C ^b   De Bruijn, Henriette S ^a   Van Der Ploeg Van Den Heuvel, Angélique ^a   Neumann, H A Martino ^a   De Haas, Ellen R M ^a   Robinson, Dominic J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Dermatology Isala Klinieken ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; CADHERIN; CD31 ANTIGEN; LEUKOCYTE ANTIGEN; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; VASCULAR ENDOTHELIAL CADHERIN;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; MOUSE; PHOTOSENSITIVITY DISORDER; RADIATION RESPONSE; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; CADHERINS; ENDOTHELIAL CELLS; MICE; PHOTOSENSITIVITY DISORDERS; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN;

EID: 84903815186     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/php.12271     Document Type: Article

References (48)

1. Soergel, P., X. Wang, H. Stepp, H. Hertel, and, P. Hillemanns, (2008) Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate. Lasers Surg. Med. 40, 611-615.
2. Soergel, P., L. Makowski, E. Makowski, C. Schippert, H. Hertel, and, P. Hillemanns, (2011) Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity. Lasers Surg. Med. 43, 713-720.
3. Soergel, P., G. F. Dahl, M. Onsrud, and, P. Hillemanns, (2012) Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate-a double-blind, dose-finding study. Lasers Surg. Med. 44, 468-474.
4. Juzeniene, A., K. P. Nielsen, L. Zhao, G. A. Ryzhikov, M. S. Biryulina, J. J. Stamnes, K. Stamnes, and, J. Moan, (2008) Changes in human skin after topical PDT with hexyl aminolevulinate. Photodiagnosis Photodyn. Ther. 5, 176-181.
5. Bader, M. J., H. Stepp, W. Beyer, T. Pongratz, R. Sroka, M. Kriegmair, D. Zaak, M. Welschof, D. Tilki, C. G. Stief, and, R. Waidelich, (2012) Photodynamic therapy of bladder cancer-a phase I study using hexaminolevulinate (HAL). Urol. Oncol. 20, 20.
6. Dognitz, N., D. Salomon, M. Zellweger, J. P. Ballini, T. Gabrecht, N. Lange, H. van den Bergh, and, G. Wagnieres, (2008) Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. J. Photochem. Photobiol., B 93, 140-148.
7. Rodriguez, L., A. Batlle, G. Di Venosa, S. Battah, P. Dobbin, A. J. Macrobert, and, A. Casas, (2006) Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br. J. Pharmacol. 147, 825-833.
8. Rud, E., O. Gederaas, A. Hogset, and, K. Berg, (2000) 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem. Photobiol. 71, 640-647.
9. Schulten, R., B. Novak, B. Schmitz, and, H. Lubbert, (2012) Comparison of the uptake of 5-aminolevulinic acid and its methyl ester in keratinocytes and skin. Naunyn Schmiedebergs Arch. Pharmacol. 385, 969-979.
10. Juzeniene, A., P. Juzenas, V. Iani, and, J. Moan, (2002) Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem. Photobiol. 76, 329-334.
11. Moan, J., L. W. Ma, A. Juzeniene, V. Iani, P. Juzenas, F. Apricena, and, Q. Peng, (2003) Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int. J. Cancer 103, 132-135.
12. Middelburg, T. A., H. S. de Bruijn, L. Tettero, A. van der Ploeg van den Heuvel Ploeg, H. A. Neumann, E. R. de Haas, and, D. J. Robinson, (2013) Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall. J. Photochem. Photobiol., B 126, 26-32.
13. de Vijlder, H. C., (2013) New Insights into Photodynamic Therapy using porphyrin precursors. Ph.D. thesis, Erasmus University Rotterdam, Rotterdam, the Netherlands.
14. Rodriguez, L., H. S. de Bruijn, G. Di Venosa, L. Mamone, D. J. Robinson, A. Juarranz, A. Batlle, and, A. Casas, (2009) Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy. J. Photochem. Photobiol., B 96, 249-254.
15. de Bruijn, H. S., C. Meijers, A. van der Ploeg-van den Heuvel, H. J. Sterenborg, and, D. J. Robinson, (2008) Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate. J. Photochem. Photobiol., B 92, 91-97.
16. de Bruijn, H. S., E. R. de Haas, K. M. Hebeda, A. van der Ploeg-van den Heuvel, H. J. Sterenborg, H. A. Neumann, and, D. J. Robinson, (2007) Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin. Photochem. Photobiol. Sci. 6, 1325-1331.
17. de Bruijn, H. S., A. G. Casas, G. Di Venosa, L. Gandara, H. J. Sterenborg, A. Batlle, and, D. J. Robinson, (2013) Light fractionated ALA-PDT enhances therapeutic efficacy in vitro; the influence of PpIX concentration and illumination parameters. Photochem. Photobiol. Sci. 12, 241-245.
18. de Haas, E. R., B. Kruijt, H. J. Sterenborg, H. A. Martino Neumann, and, D. J. Robinson, (2006) Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J. Invest. Dermatol. 126, 2679-2686.
19. Middelburg, T., H. De Bruijn, A. Van der Ploeg van den Heuvel, H. Neumann, and, D. Robinson, (2013) The effect of light fractionation with a two-hour dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin. Photodiagnosis Photodyn. Ther. 10, 703-709.
20. Sutton, T. A., H. E. Mang, S. B. Campos, R. M. Sandoval, M. C. Yoder, and, B. A. Molitoris, (2003) Injury of the renal microvascular endothelium alters barrier function after ischemia. Am. J. Physiol. Renal Physiol. 285, F191-F198.
21. Corada, M., M. Mariotti, G. Thurston, K. Smith, R. Kunkel, M. Brockhaus, M. G. Lampugnani, I. Martin-Padura, A. Stoppacciaro, L. Ruco, D. M. McDonald, P. A. Ward, and, E. Dejana, (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. USA 96, 9815-9820.
22. Bolte, S., and, F. P. Cordelieres, (2006) A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213-232.
23. de Bruijn, H. S., A. van der Ploeg-van den Heuvel, H. J. Sterenborg, and, D. J. Robinson, (2006) Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice: the influence of the dark interval. J. Photochem. Photobiol., B 85, 184-190.
24. Middelburg, T. A., F. Van Zaane, H. S. De Bruijn, A. Van Der Ploeg-van den Heuvel, H. J. Sterenborg, H. A. Neumann, E. R. De Haas, and, D. J. Robinson, (2010) Fractionated illumination at low fluence rate photodynamic therapy in mice. Photochem. Photobiol. 86, 1140-1146.
25. Henderson, B. W., and, V. H. Fingar, (1987) Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47, 3110-3114.
26. Henderson, B. W., S. M. Waldow, T. S. Mang, W. R. Potter, P. B. Malone, and, T. J. Dougherty, (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 45, 572-576.
27. Henderson, B. W., and, V. H. Fingar, (1989) Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem. Photobiol. 49, 299-304.
28. Robinson, D. J., H. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown, and, W. M. Star, (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem. Photobiol. 67, 140-149.
29. Robinson, D. J., H. S. de Bruijn, W. J. de Wolf, H. J. Sterenborg, and, W. M. Star, (2000) Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem. Photobiol. 72, 794-802.
30. Robinson, D. J., H. S. de Bruijn, W. M. Star, and, H. J. Sterenborg, (2003) Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochem. Photobiol. 77, 319-323.
31. de Vijlder, H. C., H. J. Sterenborg, H. A. Neumann, D. J. Robinson, and, E. R. de Haas, (2012) Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. Acta Derm. Venereol. 92, 641-647.
32. Chang, C. J., S. F. Ma, and, F. C. Wei, (1999) In vitro and in vivo photosensitizing capabilities of 5-ALA in vascular endothelial cells. Changgeng Yi Xue Za Zhi 22, 181-188.
33. Bedlow, A. J., A. W. Stanton, S. Cliff, and, P. S. Mortimer, (1999) Basal cell carcinoma-an in-vivo model of human tumour microcirculation? Exp. Dermatol. 8, 222-226.
34. Grunt, T. W., A. Lametschwandtner, and, O. Staindl, (1985) The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopic study on vascular corrosion casts. Microvasc. Res. 29, 371-386.
35. Wang, K. K., W. J. Cottrell, S. Mitra, A. R. Oseroff, and, T. H. Foster, (2009) Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT. Lasers Surg. Med. 41, 686-696.
36. Becker, T. L., A. D. Paquette, K. R. Keymel, B. W. Henderson, and, U. Sunar, (2010) Monitoring blood flow responses during topical ALA-PDT. Biomed. Opt. Express. 2, 123-130.
37. Middelburg, T. A., S. C. Kanick, E. R. de Haas, H. J. Sterenborg, A. Amelink, M. H. Neumann, and, D. J. Robinson, (2011) Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis. J. Biophotonics 4, 721-730.
38. Gold, M. H., V. L. Bradshaw, M. M. Boring, T. M. Bridges, and, J. A. Biron, (2006) Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol. Surg. 32, 795-801; discussion 801-3.
39. Sanclemente, G., L. Medina, J. F. Villa, L. M. Barrera, and, H. I. Garcia, (2011) A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage. J. Eur. Acad. Dermatol. Venereol. 25, 49-58.
40. Li, W., I. Yamada, K. Masumoto, Y. Ueda, and, K. Hashimoto, (2010) Photodynamic therapy with intradermal administration of 5-aminolevulinic acid for port-wine stains. J. Dermatolog. Treat. 21, 232-239.
41. Eiselein, L., D. W. Wilson, M. W. Lame, and, J. C. Rutledge, (2007) Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am. J. Physiol. Heart Circ. Physiol. 292, H2745-H2753.
42. Kidoya, H., H. Naito, and, N. Takakura, (2010) Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115, 3166-3174.
43. Ota, H., M. Matsumura, N. Miki, and, H. Minamitami, (2009) Photochemically induced increase in endothelial permeability regulated by RhoA activation. Photochem. Photobiol. Sci. 8, 1401-1407.
44. Endlicher, E., P. Rummele, F. Hausmann, R. Krieg, R. Knuchel, H. C. Rath, J. Scholmerich, and, H. Messmann, (2001) Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon. Br. J. Cancer 85, 1572-1576.
45. Juzeniene, A., P. Juzenas, L. W. Ma, V. Iani, and, J. Moan, (2006) Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Br. J. Dermatol. 155, 791-799.
46. Marti, A., P. Jichlinski, N. Lange, J. P. Ballini, L. Guillou, H. J. Leisinger, and, P. Kucera, (2003) Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J. Urol. 170, 428-432.
47. Casas, A., H. Fukuda, G. Di Venosa, and, A. M. Batlle, (2000) The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization. Br. J. Dermatol. 143, 564-572.
48. Casas, A., C. Perotti, H. Fukuda, L. Rogers, A. R. Butler, and, A. Batlle, (2001) ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization. Br. J. Cancer 85, 1794-1800.